Back to Publications
January, 2024
BlueClinical recognized by Agência Nacional de Inovação (ANI)
BlueClinical recognized by Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research
BlueClinical, an Astrum company has been recognized by the Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research.
The renewal of this 8-year certification not only underscores our continued dedication to innovation, but also allows us to strengthen our support in bringing scientific innovation to patients, by providing generous financial benefits to our pharma, biotech and medtech clients.
Other Publication
BlueClinical is a founding member of the new pan-European CRO Astrum.
BlueClinical is a founding member of the new pan-European CRO Astrum. For more information about the new range of available services, visit the new Company's website at www.astrumcro.com.
BlueClinical @ Swiss Biotech Day 2023
BlueClinical will be present at Swiss Biotech Day 2023. It will be held on April 24-25, 2023 in Basel, Switzerland. Contact us to schedule a meeting at: bd@blueclinical.pt
